Clinical Trial Update: Misoprostol Versus Oxytocin for Prevention of Post Partum Hemorrhage [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing misoprostol with oxytocin for prevention of postpartum hemorrhage has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• Cytotec (misoprostol)
• Pitocin (oxytocin)

Snippet

Sponsor: Hormozgan University of Medical Sciences | Conditions: Post Partum Hemorrhage | Phase 1 | Status: COMPLETED